Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

Cervical cancer, the most common cancer affecting women in developing countries, is
caused by persistent infection with" high-risk" genotypes of human papillomaviruses (HPV) …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

Background Prophylactic human papillomavirus (HPV) vaccines have to provide sustained
protection. We assessed efficacy, immunogenicity, and safety of the HPV-16/18 AS04 …

BACKGROUND: Prophylactic human papillomavirus (HPV) vaccines have to provide
sustained protection. We assessed efficacy, immunogenicity, and safety of the HPV-16/18 …

Worldwide, cervical cancer is the second most common cancer of women. Less-developed
countries bear the greatest burden in terms of morbidity and mortality, largely due to the lack …

Cervical cancer remains a leading cause of death for women in the developing world, and
the treatment of preneoplastic cervical lesions is a considerable public-health burden in the …

Human papillomavirus (HPV) causes cervical cancer in half a million women each year, and
two genotypes, 16 and 18, account for about 70% of all cervical cancers worldwide. 1 Two …

The two licensed bivalent and quadrivalent human papillomavirus (HPV) L1 (the major
papillomavirus virion protein) virus-like particle (VLP) vaccines are regarded as safe …

Although available human papillomavirus (HPV) vaccines have high efficacy against
incident infection and disease caused by HPV types that they specifically target, new …